17. Effects of Cariprazine on Negative Symptoms, Cognitive Impairment, and Prosocial Functioning in Patients With Predominant Negative Symptoms: Post Hoc Analysis of a Phase III, Placebo-, and Active-Controlled Study

Background: Negative symptoms and cognitive deficits are core symptoms of schizophrenia that have proven to be difficult to treat and are associated with poor social/vocational functioning. Cariprazine (CAR), a D3/D2 receptor partial agonist, is approved in the United States for the treatment of sch...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Schizophr Bull
Hlavní autoři: Daniel, David, Nasrallah, Henry, Earley, Willie, Durgam, Suresh, Lu, Kaifeng, Szatmári, Balázs, Laszlovszky, István, Németh, György, Patel, Mehul
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475488/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx021.036
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky